Pfizer, Moderna may apply soon for full authorization in PH — Galvez

enablePagination: false
maxItemsPerPage: 10
totalITemsFound:
maxPaginationLinks: 10
maxPossiblePages:
startIndex:
endIndex:

Metro Manila (CNN Philippines, August 23) — Vaccine czar Carlito Galvez, Jr. said Monday that pharmaceutical firms Pfizer and Moderna may apply for full authorization soon.

“Once na-approve na sa mga countries nila, they will also apply to us. Most likely ang nakikita namin dito, if they will have September (approval) sa kanila, they will apply in October. Maybe sa December or first quarter (next year), there will be full commercialization of the vaccines,” said Galvez in a Palace briefing.

[Translation: Once they are approved in their countries, they will also apply to us. Most likely, what we see here, if they will be approved by September in their country, they will apply in October. Maybe in December or first quarter next year, there will be full commercialization of the vaccines.]

Later in the day, the United States FDA granted full approval to the Pfizer-BioNTech COVID-19 vaccine for people at least 16 years of age.

Moderna, also an American drugmaker, has already applied for full authorization in the U.S.

Both brands have only been allowed emergency use by Philippine authorities. If their full authorization applications are approved in the country, Food and Drug Administration director general Eric Domingo told CNN Philippines in a text message that their vaccines will be available for commercial use.

This means hospitals can also procure their own vaccine supply and the vaccines will be more accessible to the public, he added.

Pfizer-BioNTech and Moderna, both American drugmakers, have already applied for full authorization in the United States.

Both brands have only been granted emergency use authorization by Philippine and U.S. authorities.

The national government earlier said it is considering prioritizing the procurement of more vaccines from Pfizer and Moderna.

Some private companies have already bought Moderna vaccines for their own employees. A deal is also in the works for companies to purchase up to a million doses of Pfizer for their employees’ dependents amid the threat of the Delta variant.